The Berlin-Canberra alliance addresses fundamental issues in malaria through an International Research Training Program (IRTG 2290). Molecular insights into Plasmodium infections can generate novel evidence-based strategies to develop curative and prophylactic drugs, and immunization strategies that elicit lasting protection against the disease.
The program covers four research areas:
All research projects will involve work carried out in both Berlin and Canberra and PhD students will graduate with a dual PhD from both the Humboldt University and the Australian National University. PhD students in the program will have the opportunity to participate in a customized training program that includes voluntary internships and that will supports students in acquiring critical skills to prepare for increasingly globalized and competitive public and private job markets.
The IRTG 2290 is a member program of the Graduate School at the IRI Life Sciences and funded by the German Research Council.
The image on our website header depicts the sporozoite stage in the life-cycle of the malaria parasite. This image was kindly provided by Dr. Volker Brinkmann, Head of Microscopy at the Max Planck Institute for Infection Biology, in Berlin.
Keep your eye on
"Ready to Beat Malaria"
Check out the Issue Highlight in Cell Reports coauthored by IRTG Spokesperson Kai Matuschewski.
Matz et al., 2018. Cell Reports. 23(3) 756–767
See also HU Press Release (in German)
April 25, 2018 - 4 pm IRI Life
Sciences, 3rd Floor
David Baker will give a talk on "The role of cyclic nucleotide signalling in malaria parasites and the potential for new drugs"
To meet the speaker please contact Theresa Störiko
April 12-13, 2018
ZIBI Retreat Seehotel Rheinsberg
PhD Scholarships Available at ANU - Join the Alliance! See applications